Federal Register / Vol. 77, No. 32 / Thursday, February 16, 2012 / Notices 9251 

can also be submitted by email to 

DCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2012–3645 Filed 2–15–12; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Designation of a Class of Employees 

for Addition to the Special Exposure 

Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice of a 

decision to designate a class of 

employees from the Linde Ceramics 

Plant in Tonawanda, New York, as an 

addition to the Special Exposure Cohort 

(SEC) under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000. On February 2, 

2012, the Secretary of HHS designated 

the following class of employees as an 

addition to the SEC: 

All Atomic Weapons Employees who 

worked in any area at the Linde Ceramics 

Plant in Tonawanda, New York, from 

November 1, 1947, through December 31, 

1953, for a number of work days aggregating 

at least 250 work days, occurring either 

solely under this employment or in 

combination with work days within the 

parameters established for one or more other 

classes of employees included in the SEC. 

This designation will become effective 

on March 3, 2012, unless Congress 

provides otherwise prior to the effective 

date. After this effective date, HHS will 

publish a notice in the Federal Register 

reporting the addition of this class to the 

SEC or the result of any provision by 

Congress regarding the decision by HHS 

to add the class to the SEC. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

NIOSH, 4676 Columbia Parkway, MS 

C–46, Cincinnati, OH 45226, Telephone 

1–877–222–7570. Information requests 

can also be submitted by email to 

DCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2012–3646 Filed 2–15–12; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Determination Concerning a Petition 

To Add a Class of Employees to the 

Special Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice of a 

determination concerning a petition to 

add a class of employees from the 

Hooker Electrochemical Company in 

Niagara Falls, New York, to the Special 

Exposure Cohort (SEC) under the Energy 

Employees Occupational Illness 

Compensation Program Act of 2000 

(EEOICPA), 42 U.S.C. 7384q. On 

February 2, 2012, the Secretary of HHS 

determined that the following class of 

employees does not meet the statutory 

criteria for addition to the SEC as 

authorized under EEOICPA: 

All employees who worked in any location 

at the Hooker Electrochemical Corporation 

during the operational period from January 1, 

1943, through December 31, 1948, and during 

the residual period from January 1, 1949, to 

December 31, 1976. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health (NIOSH), 4676 

Columbia Parkway, MS C–46, 

Cincinnati, OH 45226, Telephone 

1–877–222–7570. Information requests 

can also be submitted by email to 

DCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2012–3644 Filed 2–15–12; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Solicitation of Nominations for 

Membership on the Secretary’s 

Advisory Committee on Human 

Research Protections 

AGENCY: Department of Health and 

Human Services, Office of the Secretary, 

Office of the Assistant Secretary for 

Health, Office for Human Research 

Protections. 

ACTION: Notice. 

Authority: 42 U.S.C. 217a, Section 222 of 

the Public Health Service Act, as amended. 

The Committee is governed by the provisions 

of Public Law 92–463, as amended (5 U.S.C. 

Appendix 2), which sets forth standards for 

the formation and use of advisory 

committees. 

SUMMARY: The Office for Human 

Research Protections (OHRP), a program 

office in the Office of the Assistant 

Secretary for Health, Department of 

Health and Human Services (HHS), 

previously published a notice (76 FR 

243, 19 Dec 2011, pp. 78660–78661) 

seeking nominations of qualified 

candidates to be considered for 

appointment as members of the 

Secretary’s Advisory Committee on 

Human Research Protections (SACHRP). 

OHRP would like to announce a four 

week extension of the SACHRP 

nomination period. As a result of this 

extension, the nomination period will 

now end at the close of business on 

March 16, 2012. 

DATES: Nominations for membership on 

the Committee must be received no later 

than March 16, 2012. 

ADDRESSES: Nominations should be 

mailed or delivered to Dr. Jerry 

Menikoff, Director, Office for Human 

Research Protections, Department of 

Health and Human Services, 1101 

Wootton Parkway, Suite 200, Rockville, 

MD 20852. Nominations will not be 

accepted by email or by facsimile. 

FOR FURTHER INFORMATION CONTACT: Julia 

Gorey, Executive Director, SACHRP, 

Office for Human Research Protections, 

1101 Wootton Parkway, Suite 200, 

Rockville, MD 20852, telephone: 240– 

453–8141. A copy of the Committee 

charter and list of the current members 

can be obtained by contacting Ms. 

Gorey, accessing the SACHRP Web site 

at www.hhs.gov/ohrp/sachrp, or 

requesting them via email at 

sachrp@osophs.dhhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Committee provides advice on matters 

pertaining to the continuance and 

improvement of functions within the 

authority of HHS directed toward 

protections for human subjects in 

research. Specifically, the Committee 

provides advice relating to the 

responsible conduct of research 

involving human subjects with 

particular emphasis on special 

populations such as neonates and 

children, prisoners, the decisionally 

impaired, pregnant women, embryos 

and fetuses; individuals and 

populations in international studies, 

investigator conflicts of interest and 

research involving individually 

identifiable samples, data or 

information. 

In addition, the Committee is 

responsible for reviewing selected 

ongoing work and planned activities of 


srobinson on DSK4SPTVN1PROD with NOTICES
9252 Federal Register / Vol. 77, No. 32 / Thursday, February 16, 2012 / Notices 

OHRP and other offices or agencies 

within HHS responsible for human 

subjects protection. These evaluations 

may include, but are not limited to, a 

review of assurance systems, the 

application of minimal research risk 

standards, the granting of waivers, 

education programs sponsored by 

OHRP, and the ongoing monitoring and 

oversight of institutional review boards 

and the institutions that sponsor 

research. 

Nominations: OHRP is requesting 

nominations to fill four positions for 

voting members of SACHRP. Two 

positions will become vacant in July 

and two in October, 2012. Nominations 

of potential candidates for consideration 

are being sought from a wide array of 

fields, including, but not limited to: 

public health and medicine, behavioral 

and social sciences, health 

administration, and biomedical ethics. 

To qualify for consideration of 

appointment to the Committee, an 

individual must possess demonstrated 

experience and expertise in any of the 

several disciplines and fields pertinent 

to human subjects protection or clinical 

research. 

The individuals selected for 

appointment to the Committee can be 

invited to serve a term of up to four 

years. Committee members receive a 

stipend and reimbursement for per diem 

and any travel expenses incurred for 

attending Committee meetings or 

conducting other business in the 

interest of the Committee. Interested 

applicants may self-nominate. 

Nominations should be typewritten. 

The following information should be 

included in the package of material 

submitted for each individual being 

nominated for consideration: (1) A letter 

of nomination that clearly states the 

name and affiliation of the nominee, the 

basis for the nomination (i.e., specific 

attributes which qualify the nominee for 

service in this capacity), and a statement 

that the nominee is willing to serve as 

a member of the Committee; (2) the 

nominator’s name, address, daytime 

telephone number, and the home or 

work address, telephone number, and 

email address of the individual being 

nominated; and (3) a current copy of the 

nominee’s curriculum vitae. Federal 

employees should not be nominated for 

consideration of appointment to this 

Committee. 

The Department makes every effort to 

ensure that the membership of HHS 

Federal advisory committees is fairly 

balanced in terms of points of view 

represented and the committee’s 

function. Every effort is made to ensure 

that individuals from a broad 

representation of geographic areas, 

women and men, ethnic and minority 

groups, and the disabled are given 

consideration for membership on HHS 

Federal advisory committees. 

Appointment to this Committee shall be 

made without discrimination on the 

basis of age, race, ethnicity, gender, 

sexual orientation, disability, and 

cultural, religious, or socioeconomic 

status. 

Individuals who are selected to be 

considered for appointment will be 

required to provide detailed information 

regarding their financial holdings, 

consultancies, and research grants or 

contracts. Disclosure of this information 

is necessary in order to determine if the 

selected candidate is involved in any 

activity that may pose a potential 

conflict with the official duties to be 

performed as a member of SACHRP. 

Dated: February 10, 2012. 

Jerry Menikoff, 

Director, Office for Human Research 

Protections Executive Secretary, Secretary’s 

Advisory Committee on Human Research 

Protections. 

[FR Doc. 2012–3625 Filed 2–15–12; 8:45 am] 

BILLING CODE 4150–36–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Meeting for Software Developers on 

the Technical Specifications for 

Common Formats for Patient Safety 

Data Collection and Event Reporting 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of public meeting. 

SUMMARY: The Patient Safety and 

Quality Improvement Act of 2005, 42 

U.S.C. 299b–21 to b–26, (Patient Safety 

Act) provides for the formation of 

Patient Safety Organizations (PSOs), 

which collect, aggregate, and analyze 

confidential information regarding the 

quality and safety of health care 

delivery. The Patient Safety Act (at 42 

U.S.C. 299b–23) authorizes the 

collection of this information in a 

standardized manner, as explained in 

the related Patient Safety and Quality 

Improvement Final Rule, 42 CFR part 3 

(Patient Safety Rule), published in the 

Federal Register on November 21, 2008: 

73 FR 70731–70814. AHRQ coordinates 

the development of a set of common 

definitions and reporting formats 

(Common Formats) that allow health 

care providers to voluntarily collect and 

submit standardized information 

regarding patient safety events. In order 

to support the Common Formats, AHRQ 

has provided technical specifications to 

promote standardization by ensuring 

that data collected by PSOs and other 

entities are clinically and electronically 

comparable. More information on the 

Common Formats, including the 

technical specifications, can be obtained 

through AHRQ’s PSO Web site: http:// 

www.PSO.AHRQ.GOV/index.html. 

The purpose of this notice is to 

announce a meeting to discuss the 

Common Formats technical 

specifications. This meeting is designed 

as an interactive forum where PSOs and 

software developers can provide input 

on these technical specifications. AHRQ 

especially requests input from those 

entities which have used AHRQ’s 

technical specifications and 

implemented, or plan to implement, the 

formats electronically. 

DATES: The meeting will be held from 10 

a.m. to 3:30 p.m. on April 12, 2012. 

ADDRESSES: The meeting will be held at 

the Hyatt Regency Bethesda, 7400 

Wisconsin Avenue, Bethesda, MD 

20814. 

FOR FURTHER INFORMATION CONTACT: 

Susan Grinder, Center for Quality 

Improvement and Patient Safety, AHRQ, 

540 Gaither Road, Rockville, MD 20850; 

Telephone (toll free): (866) 403–3697; 

Telephone (local): (301) 427–1111; TTY 

(toll free): (866) 438–7231; TTY (local): 

(301) 427–1130; Email: 

PSO@AHRQ.HHS.GOV. 

If sign language interpretation or other 

reasonable accommodation for a 

disability is needed, please contact the 

Food and Drug Administration (FDA) 

Office of Equal Employment 

Opportunity and Disability Management 

at (301) 827–4840, no later than March 

28, 2012. 

SUPPLEMENTARY INFORMATION: 

Background 

The Patient Safety Act and Patient 

Safety Rule establish a framework by 

which doctors, hospitals, skilled 

nursing facilities, and other health care 

providers may voluntarily report 

information regarding patient safety 

events and quality of care. Information 

that is assembled and developed by 

providers for reporting to PSOs and the 

information received and analyzed by 

PSOs—called ‘‘patient safety work 

product’’—is privileged and 

confidential. Patient safety work 

product is used to identify events, 

patterns of care, and unsafe conditions 

that increase risks and hazards to 

patients. Definitions and other details 

about PSOs and patient safety work 

product are included in the Patient 

Safety Rule. 


srobinson on DSK4SPTVN1PROD with NOTICES